• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同种异体反应性与肿瘤抗原:通过用正常细胞对小鼠进行同种异体免疫来产生同基因抗淋巴瘤杀伤淋巴细胞。

Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.

作者信息

Sensi M L, Parenza M, Parmiani G

出版信息

J Natl Cancer Inst. 1983 Feb;70(2):291-7.

PMID:6571938
Abstract

The possibility of obtaining a syngeneic antitumor effect by immunization with normal allogeneic cells was investigated by tests of the lytic activity of peritoneal exudate cells (PEC) of BALB/c mice immunized with lymphoid cells of either a single strain or a pool of six different allogeneic strains on the syngeneic Moloney virus-induced lymphoma YC8 target and on one of its clones designated YC8-D1. Significant cytotoxicity on both targets but not on two other BALB/c lymphomas was obtained with PEC of BALB/c mice singly immunized to the non-H-2-incompatible but H-2-compatible DBA/2 or B10.D2 lymphoid cells. The lack of lysis of YC8 cells by PEC of BALB/c mice immune to B10.A (H-2k,d) suggests that the in vitro killing was restricted by Kd-IEd region products of the major histocompatibility complex. Pool immunization was effective in generating antitumor cytotoxic lymphocytes only when DBA/2 lymphoid cells were included in the pool. The pattern of reactivity of effectors elicited in (BALB/c x DBA/2)F1 and in (BALB/c x B10.D2)F1 mice by immunization with DBA/2 and B10.D2 cells showed that at least two sets of antigens are recognized on YC8 targets, one shared by DBA/2 and B10.D2 tissues and the other expressed by DBA/2 cells only. Cold target blocking experiments indicated that the same effectors recognized non-H-2 antigens of DBA/2 and the cross-reacting YC8 determinants. The antitumor effect was mediated by T-cells, since it was abrogated by treatment of effectors with anti-Thy 1.2 serum plus complement. These data indicate that determinants defined by cytotoxic T-lymphocytes are expressed on the BALB/c lymphoma YC8 and cross-react with non-H-2 antigens of DBA/2 and B10.D2 strains.

摘要

通过用正常同种异体细胞免疫来获得同基因抗肿瘤效应的可能性,已通过对BALB/c小鼠腹腔渗出细胞(PEC)的裂解活性进行检测来研究。这些BALB/c小鼠用单一品系或六个不同同种异体品系的混合淋巴细胞进行免疫,然后检测其对同基因莫洛尼病毒诱导的淋巴瘤YC8靶细胞及其一个名为YC8-D1的克隆的裂解活性。用BALB/c小鼠单独免疫非H-2不相容但H-2相容的DBA/2或B10.D2淋巴细胞后获得的PEC,对这两个靶细胞均有显著的细胞毒性,但对另外两种BALB/c淋巴瘤则无此作用。对B10.A(H-2k,d)免疫的BALB/c小鼠的PEC不能裂解YC8细胞,这表明体外杀伤作用受主要组织相容性复合体的Kd-IEd区域产物限制。只有当混合淋巴细胞中包含DBA/2淋巴细胞时,混合免疫才有效地产生抗肿瘤细胞毒性淋巴细胞。用DBA/2和B10.D2细胞免疫(BALB/c×DBA/2)F1和(BALB/c×B10.D2)F1小鼠所引发的效应细胞的反应模式表明,在YC8靶细胞上至少识别出两组抗原,一组由DBA/2和B10.D2组织共享,另一组仅由DBA/2细胞表达。冷靶阻断实验表明,相同的效应细胞识别DBA/2的非H-2抗原和交叉反应的YC8决定簇。抗肿瘤效应由T细胞介导,因为用抗Thy 1.2血清加补体处理效应细胞可消除该效应。这些数据表明,细胞毒性T淋巴细胞所定义的决定簇在BALB/c淋巴瘤YC8上表达,并与DBA/2和B10.D2品系的非H-2抗原发生交叉反应。

相似文献

1
Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.同种异体反应性与肿瘤抗原:通过用正常细胞对小鼠进行同种异体免疫来产生同基因抗淋巴瘤杀伤淋巴细胞。
J Natl Cancer Inst. 1983 Feb;70(2):291-7.
2
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.同种异体抗原诱导的针对同基因肿瘤细胞的细胞毒性:克隆水平分析。
J Immunol. 1984 Jun;132(6):3218-25.
3
Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.肿瘤细胞与同种异体正常组织之间的交叉反应。在H-2和非H-2同种异体免疫的BALB/c小鼠中对同基因淋巴瘤生长的抑制。
Int J Cancer. 1982 Mar 15;29(3):323-32. doi: 10.1002/ijc.2910290316.
4
Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.次要组织相容性抗原的诱导与特性。体外特异性原发性细胞毒性T淋巴细胞反应。
J Immunol. 1988 Feb 1;140(3):723-9.
5
Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.L5178Y细胞上的交叉反应抗原,在肿瘤休眠状态建立过程中作为细胞毒性T淋巴细胞裂解的靶标。
Cancer Res. 1982 Sep;42(9):3607-16.
6
Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.对同基因肿瘤的细胞介导免疫反应。I. 两种不同CTL效应途径的鉴定,这两种途径在抗原特异性、遗传调控和细胞表面表型方面存在差异。
J Immunol. 1986 Feb 15;136(4):1521-7.
7
Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.DBA/2淋巴瘤L1210及其亚系的差异抗原表达:同基因单克隆抗体所定义的与C3H乳腺肿瘤的交叉反应性。
Cancer Res. 1983 Jun;43(6):2592-9.
8
DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.BALB/c淋巴瘤上的DBA/2样次要组织相容性抗原。一种能裂解肿瘤并阻断BALB/c抗肿瘤和抗DBA/2效应细胞的BALB/c抗DBA/2血清。
Int J Cancer. 1985 Nov 15;36(5):617-22. doi: 10.1002/ijc.2910360516.
9
T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.T淋巴细胞对多种次要组织相容性抗原的反应会产生自身主要组织相容性复合体限制的和交叉反应性细胞毒性T淋巴细胞。
Transplantation. 1994 Jul 15;58(1):59-67.
10
Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.F1杂种抗亲本H-2d细胞介导的淋巴细胞溶解的靶决定簇:由D端控制的自身抗原。
J Immunol. 1983 May;130(5):2429-33.

引用本文的文献

1
Murine Leukemia-Derived Extracellular Vesicles Elicit Antitumor Immune Response.鼠白血病衍生的细胞外囊泡引发抗肿瘤免疫反应。
J Blood Med. 2021 May 17;12:277-285. doi: 10.2147/JBM.S308861. eCollection 2021.
2
Induction of anti-leukemic responses by stimulation of leukemic CD3+ cells with allogeneic stimulator cells.通过用同种异体刺激细胞刺激白血病CD3 +细胞诱导抗白血病反应。
Exp Hematol Oncol. 2018 Oct 4;7:25. doi: 10.1186/s40164-018-0118-5. eCollection 2018.
3
Immunotherapy of a murine T cell lymphoma localized to the brain.
针对局限于脑部的小鼠T细胞淋巴瘤的免疫疗法。
J Neurooncol. 2000 Mar;47(1):1-10. doi: 10.1023/a:1006475516746.
4
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes.体外同种致敏外周血淋巴细胞对自体人黑色素瘤细胞的裂解作用。
Cancer Immunol Immunother. 1982;14(2):99-104. doi: 10.1007/BF00200176.
5
In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.通过同种致敏在体外引发针对非免疫原性小鼠肿瘤的细胞毒性反应。
Cancer Immunol Immunother. 1984;17(2):117-23. doi: 10.1007/BF00200047.
6
Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.通过同基因抗DBA/2免疫淋巴细胞对BALB/c淋巴瘤进行过继性免疫治疗:效应细胞群体的特征及宿主非T细胞作用的证据
Cancer Immunol Immunother. 1985;20(3):198-204. doi: 10.1007/BF00205576.
7
Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma.患者淋巴细胞的同种异体刺激可产生对自体黑色素瘤具有细胞毒性的T细胞和NK样细胞。
Br J Cancer. 1985 Jul;52(1):73-80. doi: 10.1038/bjc.1985.151.
8
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.对一种与正常DBA/2细胞发生交叉反应的BALB/c淋巴瘤的细胞免疫反应及过继性免疫治疗的分析。
Cancer Immunol Immunother. 1986;21(3):199-204. doi: 10.1007/BF00199362.
9
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.对肺转移性黑色素瘤患者进行自体、同种异体激活的富含辅助细胞淋巴细胞的全身给药。一项I期研究。
Cancer Immunol Immunother. 1986;21(2):148-55. doi: 10.1007/BF00199863.
10
Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization.针对同基因鼠肿瘤具有反应性的细胞毒性T淋巴细胞及其特异性抑制性T细胞均由体外同种致敏诱导产生。
J Exp Med. 1990 Apr 1;171(4):1057-71. doi: 10.1084/jem.171.4.1057.